Did you know?

ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.  

Learn more >>

Free Newsletter

Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!

See preview >>

  Email address:
   

Zhangjiang Hi-tech Park Sets Up $147 Million Life Science Fund

publication date: Apr 1, 2009

A 1 billion RMB ($147 million) fund has been established by the Zhangjiang Hi-tech Zone in Shanghai to support young life science companies. Called the Zhangjiang Biopharmaceutical Industry Fund, it will assist companies with biopharmaceutical, medical device, diagnostic reagent and traditional Chinese medicine products. To qualify, the projects need to be approved for clinical trials or production/marketing, or be about to enter the clinical investigation stage. More details...



Sorry this page is available to subscribers only.
If you're not a subscriber why not subscribe today?

If you are already a subscriber, please login.

If you believe you should have received this message in error, please contact us.


 

To gain access to the members only content click here to subscribe.

You will be given immediate access to premium content on the site.

ChinaBio® News

Greg Scott BIO-Europe Interview
Greg Scott Interviewed at BIO-Europe Spring

How to bring your China assets to China in 8 minutes

Greg Scott Mendelspod Interview
"Mr. Bio in China."
Mendelspod Interview

Multinational pharma held to a higher standard in China

Partner Event
November 2-3, 2023 | Shanghai
November 7-8, 2023 | Digital